Online VTE Curriculum

UPDATED ONLINE VTE CURRICULUM WITH NO-COST CONTINUING EDUCATION (CE)

Stop the Clot® – What Every Healthcare Professional Should Know

ACTIVITY NUMBER: WB4010

Origination Date:  October 10, 2018
Expiration Date:  October 10, 2020


Program Description:

This self-paced, online course for healthcare professionals provides the most current foundational information and clinical considerations to assess and treat patients with blood clots and clotting disorders, or those at risk of blood clots, to improve the ability of healthcare professionals to manage these patients.

Target Audience:

The target audience for this curriculum includes: Physicians, physician assistants, pharmacists, nurses, nurse practitioners, and other healthcare professionals.

Course Content:

The online course is presented in six lessons, including:

  • Basics of Blood Clots
  • Thrombophilia & Blood Clots
  • Anticoagulation Medication
  • Post Thrombotic Syndrome
  • Pulmonary Hypertension
  • Prevention of Blood Clots

Objectives:

At the conclusion of the session or online course, participants will be able to:

  • Explain three signs and symptoms of clots, including deep vein thrombosis (DVT) and pulmonary embolism (PE).
  • Describe three factors that increase the risk of developing a blood clot in the form of a DVT and/or PE.
  • Describe three management considerations for the use of anticoagulant medications.
  • Explain three signs and symptoms of post-thrombotic syndrome that providers should include in patient education plans for blood clot survivors.
  • Explain two facts about pulmonary hypertension and its relationship to DVT.
  • Describe three appropriate treatment/management options to prevent clot recurrence and secondary complication.

Format:

Web-based, self-paced eLearning.

Prerequisites:

Knowledge of clinical care or population health and basic pathophysiology of the human body. Computer skills, including internet, MS Word, and the ability to retrieve and/or download PDF files.

Hardware/Software:

Computer hardware (PC or MAC); internet connection; browser; PDF viewing and/or retrieval software.

Materials:

None 


Contact Information:

Lisa Fullam, Director, Communications & Health Marketing, National Blood Clot Alliance, lfullam@stoptheclot.org


Faculty/Credentials: 

Curriculum Development Work Group
  • Mary Lou Damiano, BS, RN, Ed., Assistant Director, AZ Hemophilia & Thrombosis Center, AZ Cancer Center, nursing consultant to the National Blood Clot Alliance
  • Teresa Lang, PA-C, MPAS, MT(ASCP)SH, Physician Assistant, Vascular Medicine, Mayo Clinic, Rochester, MN, nursing consultant to NBCA
  • Kathleen McCool, PharmD, BCPS, CACP, Supervisor; Clinical Pharmacy Anticoagulation and Anemia Services, Kaiser Permanente, Denver, Colorado, pharmacy consultant to NBCA
  • Darren Triller, Pharm D., President/CEO, WellScriptEd Consulting, Inc., Delmar, NY, pharmacy consultant to NBCA
  • Elizabeth (Liz) Varga MS, LGC, Genetic and Genomic Services Coordinator; Co-Director of Personalized Medicine, Nationwide Children’s Hospital, and consultant to NBCA
  • Diane Wirth, MS ANP-BC CACP, Manager, Heart Failure and VTE Clinic, Grady Memorial Hospital, Atlanta, GA, nursing consultant to NBCA
National Blood Clot Alliance Medical & Scientific Advisory Board Medical Reviewers
  • Jack Ansell, MD, Professor of Medicine, Hofstra Northwell School of Medicine, Hempstead, NY
  • Alok Khorana, MD, Professor of Medicine, Staff, Cleveland Clinic Lerner College of Medicine, Cleveland, OH

Accreditation Statements:

CME Activities with Joint Providers:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Centers for Disease Control and Prevention and National Blood Clot Alliance. The Centers for Disease Control and Prevention is accredited by the (ACCME®) to provide medical education for physicians.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 2.25 AMA PRA Category 1 Credits™.


CNE:

The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.  This activity provides 2 contact hours.


CEU:

The Centers for Disease Control and Prevention is authorized by IACET to offer 0.2 CEU’s for this program.


 

 

 

CPE:

 

The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This program is a designated event for pharmacists to receive 0.215 CEUs in pharmacy education. The Universal Activity Number is 0387-9999-18-204-H01-P.


Category:

This activity has been designated as Application-Based.

Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

Disclosure:

In compliance with continuing education requirements, all planners, presenters, and their spouses/partners must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigation use.

CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of:

  • Jack Ansell, and he wishes to disclose that he receives stock options, is a consultant and a Scientific Advisory Board member to Perosphere Inc., also is a consultant to Alere Home Monitoring.
  • Alok Khorana, and he wishes to disclose he receives honoraria as a consultant to Janssen, Bayer, Pfizer, Sanofi, Halozyme, AngioDynamics, Pharmacyte, Pharmacyclics, Incyte.
  • Elizabeth Varga, and she wishes to disclose that she had a short-term (4 month) consulting contract with Roche related to thrombophilia (FVL/factor II testing), advised on marketing and educational materials.

Planning committee discussed conflict of interest with Dr. Khorana to ensure there is no bias.

Planning committee reviewed content provided by Dr. Ansell and Ms. Varga to ensure there is no bias.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

The Centers for Disease Control and Prevention and National Blood Clot Alliance are jointly providing the CNE for this activity.

CDC did not accept commercial support for this continuing education activity.


Registration:

To use this online curriculum, you will need a computer and an Internet connection, and you will need to enable cookies in your browser.

Please address questions or comments about registration or the online curriculum to NBCA’s Director of Communications & Health Marketing at lfullam@stoptheclot.org or info@stoptheclot.org.

The National Blood Clot Alliance developed and designed this curriculum with support provided by the Centers for Disease Control and Prevention under Cooperative Agreement 1U27DD001153.

URL:

https://www.stoptheclot.org/health-professionals/curriculum/


Important Guidance: Evaluation and Continuing Education:

Continuing education for this course is only available through the CDC Training and Continuing Education Online system (CDC TCEO).  Please follow the instructions provided below. You must complete the online evaluation by 10/10/2020 to receive your continuing education or your certificate of completion.

Instructions for Obtaining Continuing Education (CE):

In order to receive continuing education (CE) for WB4010 Stop the Clot® – What Every Healthcare Professional Should Know please visit TCEO and follow these 9 Simple Steps before 10/10/2020.

Fees:

No fees are charged for CDC’s CE activities.